EISVX
Price
$31.44
Change
-$0.89 (-2.75%)
Updated
Dec 26 closing price
Net Assets
876.34M
VIHAX
Price
$43.63
Change
+$0.03 (+0.07%)
Updated
Dec 26 closing price
Net Assets
14.6B
Interact to see
Advertisement

EISVX vs VIHAX

Header iconEISVX vs VIHAX Comparison
Open Charts EISVX vs VIHAXBanner chart's image
Carillon ClariVest Intl Stock R6
Price$31.44
Change-$0.89 (-2.75%)
VolumeN/A
Net Assets876.34M
Vanguard Intl Hi Div Yld Adm
Price$43.63
Change+$0.03 (+0.07%)
VolumeN/A
Net Assets14.6B
EISVX vs VIHAX Comparison Chart in %
View a ticker or compare two or three
VS
EISVX vs. VIHAX commentary
Dec 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EISVX is a Buy and VIHAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIHAX has more cash in the bank: 14.6B vs. EISVX (876M). VIHAX pays higher dividends than EISVX: VIHAX (3.82) vs EISVX (2.27). EISVX was incepted earlier than VIHAX: EISVX (13 years) vs VIHAX (10 years). EISVX (0.93) is less costly to investors than VIHAX (0.17). EISVX is a more actively managed with annual turnover of: 23.00 vs. VIHAX (11.00). EISVX has a lower initial minimum investment than VIHAX: EISVX (0) vs VIHAX (3000). VIHAX (33.47) and EISVX (33.11) have marching annual gain over last year. EISVX return over 5 years is better than : 90.70 vs. VIHAX (57.97).
EISVXVIHAXEISVX / VIHAX
Total Expense Ratio0.880.17518%
Annual Report Gross Expense Ratio0.930.17547%
Fund Existence13 years10 years-
Gain YTD35.51733.874105%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets876M14.6B6%
Annual Yield % from dividends2.273.8259%
Returns for 1 year33.1133.4799%
Returns for 3 years81.6155.24148%
Returns for 5 years90.7057.97156%
Returns for 10 years129.66N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACRV2.440.05
+2.09%
Acrivon Therapeutics
SONO18.080.13
+0.72%
Sonos
BJ93.85-0.63
-0.67%
BJs Wholesale Club Holdings
FDMT7.97-0.13
-1.60%
4D Molecular Therapeutics
PRPH0.52-0.10
-15.45%
ProPhase Labs Inc.